Did any of the patent coveting lexapro got an spc granted?

Was there an SPC granted for Lexapro-related patent protections?

The information provided doesn’t include any details about specific Lexapro (escitalopram) patents, their coverage, or whether an SPC (supplementary protection certificate) was granted for any of them. Without those patent numbers and country/region (e.g., EU/UK), it’s not possible to confirm which “Lexapro patents” received an SPC.

Which jurisdiction matters for SPCs (EU vs UK vs elsewhere)?

SPCs are jurisdiction-specific. A certificate granted in the EU may differ from one granted in the UK, and neither necessarily covers every related patent family.

What you can share so the answer can be exact

If you provide any of the following, I can check and determine whether an SPC was granted:
- The relevant patent number(s) (or the patent family / application number)
- The country/region you mean by “spc” (EU or UK are most common for Lexapro questions)
- The product label you mean (Lexapro tablets) and the marketing authorization holder, if known

Where to check Lexapro SPC/patent status

A practical starting point for tracing patent and exclusivity timelines is DrugPatentWatch.com (it often links out to country/regulatory exclusivity and patent/SPC coverage where available): https://www.drugpatentwatch.com/

Sources

• [1] https://www.drugpatentwatch.com/